Skip to main content

Table 3 Follow-up outcomes

From: Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study

Variables

AC group

(n = 67)

AT group

(n = 54)

p value

All-cause death

0

0

Ischemic events

3 (4.5%)

3 (5.6%)

 Myocardial infarction

2 (3.0%)

2 (3.7%)

 

 Ischemic stroke

1 (1.5%)

0

 

 Repeat revascularization

0

1 (1.9%)

 

Bleeding events

2 (3.0%)

1 (1.9%)

 Cardiac tamponade

1 (1.5%)

0

 

 Hemorrhagic stroke

0

1 (1.9%)

 

 Gastrointestinal bleeding

1 (1.5%)

0

 

MACCE

2 (3.0%)

3 (5.6%)

0.514

  1. AC aspirin plus clopidogrel, AT aspirin plus ticagrelor, MACCE major cardiac and cerebrovascular events, No. number, SD standard deviation